Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis

• Päätekijät: Dwi Soelistyoningsih (Tekijä), Hani Susianti (Tekijä), Handono Kalim (Tekijä), Kusworini Handono (Tekijä), Jonny Karunia Fajar (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Interleukin-2 is being investigated as a potential therapeutic option in systemic lupus erythematosus (SLE), but the current findings regarding its effectiveness remained inconclusive. Objectives: To assess the association between the administration of low-dose interleukin-2 and the SLE...